Molecular Moments Podcasts
Taking Risks and Setting Precedent in Bioanalytical Assays for Cell & Gene Therapies
There are no bad ideas in developing bioanalytical testing, says Jim McNally, CSO of BioAgilytix. Not all ideas will work, of course. But he has…